Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing

Manufacturing

Baxter introduces Hyqvia in US to treat primary immunodeficiency By PBR Staff Writer
Baxter International and Halozyme Therapeutics have launched Hyqvia as a subcutaneous immunoglobulin treatment for adult patients with primary immunodeficiency (PI) in the US.
Production & Manufacturing > Manufacturing > News
Takeda and Orexigen launch weight management drug Contrave in US By PBR Staff Writer
Takeda Pharmaceutical and Orexigen Therapeutics have launched Contrave (naltrexone HCI and bupropion HCI) extended-release tablets in the US and will be available to patients by prescription.
Production & Manufacturing > Manufacturing > News China Biologic gets approval to manufacture human prothrombin complex concentrate at Shandong Taibang facility China Biologic Products, a leading fully integrated plasma-based biopharmaceutical company in China, announced that the company has received approval from the China Food and Drug Administration for commercial manufacturing of human prothrombin complex concentrate at its Shandong Taibang facility.
Production & Manufacturing > Manufacturing > News
See more Manufacturing news

Latest Manufacturing News and Insight

View all Manufacturing news or find news targeted to your interests
Horizon Pharma acquires US rights to Pennsaid 2% from Nuvo Research
By PBR Staff Writer
Horizon Pharma has acquired the US rights to Pennsaid (diclofenac sodium topical solution) 2% (Pennsaid 2%) from Nuvo Research for $45m.
Production & Manufacturing > Manufacturing > News
Bone Biologics completes merger with AFH Acquisition X
Bone Biologics, a company developing a proprietary protein for use in bone regenerative medicine using the patented recombinant human protein known as UCB-1 (or Nell-1) for use with patients undergoing spinal fusion, has announced today the completion of a reverse merger of privately held Bone Biologics, Inc. and AFH Acquisition X, Inc, a fully-reporting company with the Securities and Exchange Commission.
Production & Manufacturing > Manufacturing > News
Ranbaxy agrees to pay $39.75m to settle Texas Medicaid litigation
By PBR Staff Writer
Ranbaxy Laboratories has agreed to pay $39.75m to resolve allegations concerning its participation in the Texas Medicaid Program.
Production & Manufacturing > Manufacturing > News
Breckenridge launches Mefenamic acid 250mg capsules
By PBR Staff Writer
US-based Breckenridge Pharmaceutical has launched Mefenamic Acid 250mg Capsules after securing final approval for its abbreviated new drug application (ANDA) from the US Food and Drug Administration (FDA).
Production & Manufacturing > Manufacturing > News
New Ebola cases may reach 10,000 per week by year end: WHO
By PBR Staff Writer
The World Health Organization (WHO) has reported that the number of people being infected with the deadly Ebola virus disease in West Africa could reach up to 10,000 a week by the end of the December.
Production & Manufacturing > Manufacturing > News
Rich Pharmaceuticals to buy Hodgkin's Lymphoma treatment rights
Rich Pharmaceuticals, Rich, a cancer therapeutics development company announced that it has entered into an agreement with Richard L. Chang Holdings, based in New Jersey for ownership to its investigational cancer patent assignment using Phorbol Esters in the treatment of Hodgkin's Lymphoma.
Production & Manufacturing > Manufacturing > News
Impax agrees to buy Tower Holdings and Lineage Therapeutics
Impax Laboratories has announced the execution of a definitive agreement under which Impax will acquire Tower Holdings, including operating subsidiaries CorePharma and Amedra Pharmaceuticals, and Lineage Therapeutics (together, the "Companies") for $700m in cash, subject to certain customary purchase price adjustments.
Production & Manufacturing > Manufacturing > News
Novartis India may face $49m penalty from NPPA for over-pricing Voveran
By PBR Staff Writer
Swiss drug-maker Novartis' India division has been reportedly fined INR3bn ($49m) by the National Pharmaceutical Pricing Authority (NPPA) for over pricing Voveran, its best-selling painkiller.
Production & Manufacturing > Manufacturing > News
Boehringer makes Striverdi Respimat inhalation spray 5 µg available in US pharmacies
By PBR Staff Writer
Boehringer Ingelheim has made available Striverdi Respimat (olodaterol) Inhalation Spray 5 µg by prescription in pharmacies across the US.
Production & Manufacturing > Manufacturing > News
FeF Chemicals - Insulin Human and Benzalkonium Chloride Products
FeF Chemicals is a Novo Nordisk company that specialises in the supply of ingredients for the biopharmaceutical and pharmaceutical industries, such as insulin human for cell culture media and cGMP manufactured quaternary ammonium compounds (usually referred to as quats) such as benzalkonium chloride, cetrimide and cetrimonium bromide.
Production & Manufacturing > Manufacturing > Suppliers
View all Manufacturing news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250